Drug combination therapy of systemic lupus erythematosus.
Miescher
P A
PA
Division of Haematology, Geneva University Hospital, Switzerland.
Favre
H
H
Lemoine
R
R
Huang
Y P
YP
D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007376:Interleukin-2 / Q000097:blood; D007677:Kidney Function Tests; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects; D015375:Receptors, Interleukin-2 / Q000032:analysis
D007074:Immunoglobulin G; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D003907:Dexamethasone; D016572:Cyclosporine; D008727:Methotrexate